0.6738
0.0068 (1.02%)
0.0068 (1.02%)
Upgrade to Real-Time
Regular Market
| Volume | 267,970 |
|
|||||
| News | - | ||||||
| Day High | 0.6799 | Low High |
|||||
| Day Low | 0.6499 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0068 | 1.02% | 0.6738 | 12:56:34 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.67 | 0.6499 | 0.6799 | 0.667 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 757 | 267,970 | $ 0.6664485 | $ 178,588 | - | 0.40 - 2.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:00:08 | 100 | $ 0.6738 | USD |
Period:
Draw Mode:
Cidara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 47.22M | 70.08M | 68.99M | $ 49.57M | $ -40.14M | -0.86 | -0.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 196.00k | 3.50% |
Cidara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6301 | 0.70 | 0.5862 | 0.6491432 | 507,087 | 0.0437 | 6.94% |
| 1 Month | 0.691 | 0.88 | 0.57 | 0.7281531 | 938,033 | -0.0172 | -2.49% |
| 3 Months | 0.45 | 0.88 | 0.40 | 0.6613241 | 551,946 | 0.2238 | 49.73% |
| 6 Months | 0.81 | 1.06 | 0.40 | 0.6778863 | 398,451 | -0.1362 | -16.81% |
| 1 Year | 1.67 | 2.39 | 0.40 | 1.18 | 522,422 | -0.9962 | -59.65% |
| 3 Years | 1.34 | 4.45 | 0.40 | 2.06 | 458,019 | -0.6662 | -49.72% |
| 5 Years | 5.75 | 8.80 | 0.40 | 2.42 | 327,337 | -5.08 | -88.28% |
Cidara Therapeutics Description
| Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. |